Alopecia Areata. Other alopecia areata
Conditions
Interventions
Intervention 1: Intervention group 1: Intra-lesional injection of triamcinolone acetonide with a dose of 2.5 mg/ml. Intervention 2: Intervention group 2: Intra-lesional injection of triamcinolone acet
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to No maximum
Inclusion criteria
Inclusion criteria: Alopecia areata patients with one or more patch lesions. Patients 15 years and older Patients who declare their full consent to participate in the study. The duration of the disease is 3 to 12 months and there is no sign of new hair growth at the site of the lesion.
Exclusion criteria
Exclusion criteria: Children Background or presence of skin diseases such as psoriasis, seborrheic dermatitis, and malignancy and infection at the site Patients with malignancy and blood dyscrasia Pregnant and lactating women Patients with mental retardation and physical disability Patients who have received topical or systemic corticosteroids and topical treatments in alopecia areata or immunosuppressive drugs over the past month. People with autoimmune, type I diabetes, etc. No seizure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number and Length of new hear at lesion site. Timepoint: Monthly. Method of measurement: Clinical Examination of Number and Length of new hear at lesion site. | — |
Secondary
| Measure | Time frame |
|---|---|
| New Hear Growth Rate. Timepoint: Monthly. Method of measurement: Clinical Examination of New Hear Growth Rate on Injection Site. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamideh Azimi Alamdari
Tabriz University of Medical Sciences
Outcome results
None listed